top of page
Till Erdmann

Angel Investor

Till is a serial founder and angel investor with over 20 years life science experience in biopharma, diagnostics, digital health, and med-tech. Founder of Myelo Therapeutics (sold to Eckert & Ziegler AG), Treamid Therapeutics (secondary exit), and IDrug. Hands-on experience in strategy development, general management and troubleshooting, fundraising, business development, and partnering. Over €40 Mio. venture capital and non-dilutive funding raised.

Prior to becoming a founder, Till worked in management consulting and subsequently in various strategy, marketing, and commercial roles at Bayer Pharma and Thermo Fisher Scientific. He is an engineer and MBA by training.

Till Erdmann
bottom of page